Mobile App in Addiction
- Conditions
- Addiction
- Interventions
- Device: ASC
- Registration Number
- NCT04133688
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Brief Summary
The sleep and behavior agendas are today very largely underused while they can be of a considerable contribution in the follow-up of the patients and the reinforcement of the therapeutic alliance. In the management of addictions, sleep disorders are a major comorbidity, these two components maintain indeed complex links: it was highlighted a bidirectional relationship between the effect of the consumption of addictive substances on sleep and conversely, the effect of sleep disorders on the consumption of products, the same is true for overexposure to screens.
- Detailed Description
The sleep and behavior agendas are today very largely underused while they can be of a considerable contribution in the follow-up of the patients and the reinforcement of the therapeutic alliance. In the management of addictions, sleep disorders are a major comorbidity, these two components maintain indeed complex links: it was highlighted a bidirectional relationship between the effect of the consumption of addictive substances on sleep and conversely, the effect of sleep disorders on the consumption of products, the same is true for overexposure to screens.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 36
- Teenagers or young adults from 12 to 18 years old (included)
- Consultant for addiction to cannabis and / or tobacco and / or alcohol and / or screen
- Treated within the Functional Unit of addictology
- For minors, after parental consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Mobile application (ASC) ASC mobile app / devise Paper diary ASC paper diary
- Primary Outcome Measures
Name Time Method Number of days filled for sleep and consumptions, usable by the doctor on the day of the consultation / after 15 days of self-evaluation required by the treatment 15 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Robert Debre Hospital
🇫🇷Paris, France